GMCTI

gene-mediated cytotoxic immunotherapy · Candel Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GMCTI, covering 2025-07-11 to 2025-07-11. Get the full timeline:

Most recent: Clinical Trial Update: Intratumoral Gene Mediated Cytotoxic Immunotherapy in Patients With Resectable Non-Small Cell Lung Cancer [Phase 1]

See pricing